Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Parkinsonism Relat Disord. 2019 Jun 23;65:172–177. doi: 10.1016/j.parkreldis.2019.06.018

Table 4:

Comparisons of responsiveness indices for QOL scales

4a: SRMs for each QOL outcome measure
Scale SRM For Intervention Group (95% CI) SRM for Control Group (95% CI)
PDQ-39 −0.30 (−0.49, −0.10)* −0.002 (−0.22, 0.21)
PROMIS-29 −0.25 (−0.45, −0.06)* −0.07 (−0.28, 0.14)
QOL-AD 0.13 (−0.09, 0.34) −0.22 (−0.42, 0.02)
McGill QOL 0.14 (−0.12, 0.35) 0.13 (−0.09, 0.34)

4b: Comparisons of SRMs
Scales Difference in SRM for Intervention Group (95% CI) Difference in SRM for Control Group (95% CI)
PDQ-39 vs. PROMIS-29 0.04 (−0.13, 0.20) −0.07 (−0.28, 0.13)
PDQ-39 vs. McGill 0.18 (−0.05, 0.43) −0.13 (−0.38, 0.12)
PDQ-39 vs. QOL-AD 0.20 (−0.03, 0.42) 0.23 (−0.03, 0.46)
PROMIS-29 vs. McGill 0.15 (−0.05, 0.37) −0.06 (−0.30, 0.19)
PROMIS-29 vs. QOL-AD 0.13 (−0.10, 0.36) 0.30 (0.05, 0.53)*
McGill vs. QOL-AD 0.01 (−0.23, 0.21) 0.34 (0.09, 0.58)*
*

p=0.05

For PDQ-39 and PROMIS-29, negative change indicates improved QOL

For QOL-AD and McGill QOL, positive change indicates improved QOL

*

p=0.05

Note: Scales were reversed as necessary so positive numbers consistently refer to improvement in QOL.